For some patients, the game may be a proxy for drugs. For most, theyll be part of a multimodal treatment. From a business perspective, eFormulations could also be a boon for drug makers bottom lines, because they would likely qualify as new formulations and extend patent protection–and profitability. Corey McCann Pears lead product will be aimed at managing general anxiety disorder through a game that encourages the player to breathe in a rhythmic pattern to stimulate the vagus nerve in the brain. The standard of care today is to take a benzodiazepine, says McCann.
For the original version including any supplementary images or video, visit http://www.fastcompany.com/3032606/innovation-agents/play-two-and-call-me-in-the-morning-inside-the-emerging-science-of-videoga

Advertisements